Skip to main content
. 2020 Sep 14;12(17):17380–17392. doi: 10.18632/aging.103737

Figure 5.

Figure 5

Impact of gene expression of CRL5 components on GBM, primary and recurrent glioma survival. The survival analysis of WHO grade IV, primary and recurrent gliomas was based on a CGGA dataset (mRNAseq_325). P values are indicated in the picture.